Naidong Ye

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease

Gvido Cebers, Robert Alexander, Samantha Budd Haeberlein et al. · Journal of Alzheimer s Disease · 2016 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +17

The first [14]cyclidene complexes: relationships between macrocyclic ring size, lacunar cavity shape, and dioxygen affinity of the cobalt-cyclidene dioxygen carriers

Jihong Chen, Naidong Ye, Nathaniel W. Alcock et al. · Inorganic Chemistry · 1993 · 24 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10

Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics

Naidong Ye, Scott A. Monk, Pankaj Daga et al. · Clinical Pharmacology in Drug Development · 2018 · 17 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +15

P1‐363: MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA (SAPPA) AND BETA (SAPPB) FRAGMENTS IN PLASMA AND CSF FROM HEALTHY INDIVIDUALS TREATED WITH BACE INHIBITOR AZD3293 IN A MULTIPLE ASCENDING DOSE STUDY: PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATE

Kina Höglund, Hugh Salter, Henrik Zetterberg et al. · Alzheimer s & Dementia · 2014 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Modeling the heteroleptic equilibria of organized molecular systems by using a double-titration technique: a novel determination of the fundamental equilibrium constants in a ternary system involving a macrocyclic cobalt(II) complex, dioxygen, and competing axial ligands

Naidong Ye, Daryle H. Busch · Inorganic Chemistry · 1991 · 10 citations

Natural Sciences, Chemistry, Inorganic Chemistry +16